BRAF and cancer: We have shown previously that depletion of the MEK/ERK kinase, BRAF decreases the permeability of the endothelial monolayer and the transmigration of cancer cells in response to thrombin and this is related to the role of BRAF exerted on the dynamical reorganization of the actin cytoskeleton [22].